Pricing Log in Create free account
Saturday 17 October 2026 Export ALGN’s income statement to Excel — free account

Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

147.31 2.03 −1.36%
Market cap
$10.6B
P/E
25.6×
Fwd P/E
20.7×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Align Technology, Inc. (ALGN) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Aug 27, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
10-Q Jun 30, 2026 P1I2: 12 added · 34 modified
P2I1A: 9 added · 2 removed · 41 modified
8-K Jul 29, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jul 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 6, 2026 5.02 Departure or appointment of directors or officers
8-K Jun 17, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 20, 2026 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 30, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 24 added · 8 removed · 88 modified
1A: 21 added · 28 removed · 91 modified
7: 26 added · 20 removed · 46 modified
8-K Feb 24, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 12, 2025 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.